Riskpilot← Back to searchSign inGet full accessID MEDPARTNER AS
ASActiveOrg 927441802Strandveien 35, 1366 LysakerAndre helsetjenester · NACE 86909Est. 20212 employees
Revenue 2022
NOK 673K
+6000% vs 2021
EBITDA margin
-408.5%
-219% vs 2021
Equity ratio
-247.4%
Financial strength
Net profit 2022
NOK -3M
-224% vs 2021
| Revenue | NOK 673K | +6000% |
| EBITDA | NOK -2,7M | -219% |
| Net profit | NOK -3M | -224% |
| Total assets | NOK 758K | +29% |
| Equity | NOK -1,9M | -233% |
| Employees | 2 | — |
Legal name
ID MEDPARTNER AS
Org number
927441802
Legal form
Aksjeselskap
NACE code
86909 · Andre helsetjenester
Founded
20. juli 2021
Share capital
NOK 64 700 000
Employees
2 (FTE)
VAT registered
No
Audit selected
No
Last report
2022-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Å yte helsetjenester og formidle helsetjenester fra legespesialister til pasienter som ønsker fornyet vurdering av pågående eller planlagt medisinsk behandling innenfor allmennhelsetjenesten, legevaktstjenesten og spesialisthelsetjenesten. Dette inkluderer medisinske vurderinger og videre behandling av aktuell sykdom eller skade, vurdering av beste behandlingsalternativ, henvisning til røntgenundersøkelser, laboratorieundersøkelser og andre medisinske undersøkelser, henvisning til sykehusavdelinger ved behov, samt alt som naturlig hører inn under dette.
Address
Strandveien 35, 1366 Lysaker
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 |
|---|---|---|
| Revenue | 11 | 673 |
| Staff expenses | −202 | −762 |
| EBITDA | −862 | −2 749 |
| Depreciation & amort. | −26 | −125 |
| EBIT | −888 | −2 874 |
| Net financials | −26 | −89 |
| Profit before tax | −913 | −2 963 |
| Tax | −0 | −0 |
| Net profit | −913 | −2 963 |
| Item | 2021 | 2022 |
|---|---|---|
| Total assets | 589 | 758 |
| Equity | −563 | −1 876 |
| Long-term debt | 500 | 1 517 |
| Short-term debt | 652 | 1 118 |
| Total debt | 1 152 | 2 635 |
EBITDA margin
-408.5%
This company
15.8%
Market median
-2685% vs market
20212022
Equity ratio
-247.4%
This company
38.2%
Market median
-748% vs market
20212022
Return on equity
-296296900.0%
This company
18.4%
Market median
-1610309339% vs market
20212022
Net profit margin
-440.3%
This company
8.1%
Market median
-5536% vs market
20212022
Asset turnover
0.89×
This company
1.12×
Market median
+21% vs market
20212022
Debt / equity
1.40×
This company
0.62×
Market median
-126% vs market
20212022
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2022 | |
| Board of Directors | 2022 | |
| Chairman | 2022 | |
| Former (1) | ||
| Board of Directors | 2021 – 2021 | |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of ID MEDPARTNER AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Indra Aamodt Strand | Board of Directors | 0 companies |
| Vidar Opland | Board of Directors | 0 companies |
| Dag Arild Aamodt Strand | Chairman | 0 companies |
| Indra Gintaliene | Board of Directors | 0 companies |